Megha Singh
Overview
Explore the profile of Megha Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh M, Verma M, Pandey S, Kumar R, Khan F, Pandey P
Endocr Metab Immune Disord Drug Targets
. 2024 Sep;
PMID: 39318018
Cancer remains a global health problem that requires constant research for the development of new treatment strategies. Flavonoids, a diverse group of naturally occurring polyphenolic compounds abundant in fruits, vegetables,...
2.
Singh M, Fayaz F, Wang J, Wambua S, Subramanian A, Reynolds J, et al.
BMC Med
. 2024 Aug;
22(1):339.
PMID: 39183290
Background: Pregnancy complications might lead to the development of autoimmune diseases in women. This review aims to summarise studies evaluating the association between pregnancy complications and the development of autoimmune...
3.
Wang J, Nirantharakumar K, Sainsbury C, Moore D, Sinclair A, Neil Thomas G, et al.
Syst Rev
. 2024 Jun;
13(1):155.
PMID: 38872216
Background: Due to increasing life expectancy, almost half of people with type 2 diabetes are aged 65 years or over worldwide. When metformin alone does not control blood sugar, the...
4.
Singh M, Wambua S, Lee S, Okoth K, Wang Z, Fayaz F, et al.
BMC Med
. 2024 Mar;
22(1):94.
PMID: 38438886
Background: There is a high prevalence of autoimmune conditions in women specially in the reproductive years; thus, the association with adverse pregnancy outcomes has been widely studied. However, few autoimmune...
5.
Wambua S, Singh M, Okoth K, Snell K, Riley R, Yau C, et al.
BMC Med
. 2024 Feb;
22(1):66.
PMID: 38355631
Background: Despite many systematic reviews and meta-analyses examining the associations of pregnancy complications with risk of type 2 diabetes mellitus (T2DM) and hypertension, previous umbrella reviews have only examined a...
6.
Pandey P, Khan F, Singh M, Verma A, Kumar H, Mazumder A, et al.
Endocr Metab Immune Disord Drug Targets
. 2023 Nov;
24(11):1241-1253.
PMID: 37997805
In recent years, dysregulation of the notch pathway has been associated with the development and progression of various cancers. Notch signaling is involved in several cellular processes, such as proliferation,...
7.
Singh M, Wambua S, Lee S, Okoth K, Wang Z, Fazla F, et al.
Lancet
. 2023 Nov;
402 Suppl 1:S84.
PMID: 37997130
Background: The prevalence of autoimmune conditions is two-fold higher in women than in men, especially during the reproductive years. Autoimmune conditions have been associated with a greater risk of adverse...
8.
Subramanian A, Lee S, Hemali Sudasinghe S, Wambua S, Phillips K, Singh M, et al.
BMJ Open
. 2023 Oct;
13(10):e073162.
PMID: 37813531
Introduction: Considering the high prevalence of polypharmacy in pregnant women and the knowledge gap in the risk-benefit safety profile of their often-complex treatment plan, more research is needed to optimise...
9.
Lee S, Hanley S, Vowles Z, Plachcinski R, Moss N, Singh M, et al.
BMC Med
. 2023 Aug;
21(1):314.
PMID: 37605204
Background: Heterogeneity in reported outcomes can limit the synthesis of research evidence. A core outcome set informs what outcomes are important and should be measured as a minimum in all...
10.
Lee S, Hanley S, Vowles Z, Plachcinski R, Azcoaga-Lorenzo A, Taylor B, et al.
BMC Pregnancy Childbirth
. 2023 Aug;
23(1):551.
PMID: 37528358
Background: Maternal multiple long-term conditions are associated with adverse outcomes for mother and child. We conducted a qualitative study to inform a core outcome set for studies of pregnant women...